Items where Author is "Rees, R"

Journal article

POWE, D.G., DHONDALAY, G.K.R., LEMETRE, C., ALLEN, T., HABASHY, H.O., ELLIS, I.O., REES, R. and BALL, G., 2014. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer. PLOS ONE, 9 (1). ISSN 1932-6203

PHATAK, V.M., CROFT, S.M., RAMESHAIAH SETTY, S.G., SCARPELLINI, A., HUGHES, D.C., REES, R., MCARDLE, S. and VERDERIO, E.A.M., 2013. Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer. Amino Acids, 44 (1), pp. 33-44. ISSN 0939-4451

VAFADAR-ISFAHANI, B., BALL, G., COVENEY, C., LEMETRE, C., BOOCOCK, D., MINTHON, L., HANSSON, O., MILES, A.K., JANCIAUSKIENE, S.M., WARDEN, D., SMITH, A.D., WILCOCK, G., KALSHEKER, N., REES, R., MATHAROO-BALL, B. and MORGAN, K., 2012. Identification of SPARC-like 1 protein as part of a biomarker panel for Alzheimer's disease in cerebrospinal fluid. Journal of Alzheimer's Disease, 28 (3), pp. 625-636. ISSN 1387-2877

TONG, D.L., BOOCOCK, D., COVENEY, C., SAIF, J., GOMEZ, S.G., QUEROL, S., REES, R. and BALL, G.R., 2011. A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studies. Clinical Proteomics, 8 (1). ISSN 1542-6416

KAY, R.G., BARTON, C., VELLOSO, C.P., BROWN, P.R., BARTLETT, C., BLAZEVICH, A.J., GODFREY, R.J., GOLDSPINK, G., REES, R., BALL, G.R., COWAN, D.A., HARRIDGE, S.D., ROBERTS, J., TEALE, P. and CREASER, C.S., 2009. High-throughput ultra-high-performance liquid chromatography/tandem mass spectrometry quantitation of insulin-like growth factor-I and leucine-rich α-2-glycoprotein in serum as biomarkers of recombinant human growth hormone administration. Rapid Communications in Mass Spectrometry, 23 (19), pp. 3173-3182. ISSN 1097-0231

BOATENG, J., KAY, R., LANCASHIRE, L., BROWN, P., VELLOSO, C., BOULOUX, P., TEALE, P., ROBERTS, J., REES, R., BALL, G., HARRIDGE, S., GOLDSPINK, G. and CREASER, C., 2009. A proteomic approach combining mass spectrometric and bioinformatics analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans. Proteomics - Clinical Applications, 3 (8), pp. 912-922. ISSN 1862-8346

LAVERSIN, S., MILES, A., BALL, G. and REES, R., 2008. Emerging breast cancer biomarkers. Current Cancer Therapy Reviews, 4 (2), pp. 79-85. ISSN 1573-3947

MATHAROO-BALL, B., MILES, A.K., CREASER, C.S., BALL, G. and REES, R., 2008. Serum biomarker profiling in cancer studies: a question of standardisation? Veterinary and Comparative Oncology, 6 (4), pp. 224-247. ISSN 1476-5829

MATHAROO-BALL, B., HUGHES, C., LANCASHIRE, L., TOOTH, D., BALL, G., CREASER, C., ELGASIM, M., REES, R., LAYFIELD, R. and ATIOMO, W., 2007. Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms. Journal of Proteome Research, 6 (8), pp. 3321-3328. ISSN 1535-3893

MATHAROO-BALL, B., BALL, G. and REES, R., 2007. Clinical proteomics: Discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches - A prostate cancer perspective. Vaccine, 25. ISSN 0264-410X

MATHAROO-BALL, B., RATCLIFFE, L., LANCASHIRE, L., UGUREL, S., MILES, A.K., WESTON, D.J., REES, R., SCHADENDORF, D., BALL, G. and CREASER, C.S., 2007. Diagnostic biomarkers differentiating metastatic melanoma patients from healthy controls identified by an integrated MALDI-TOF mass spectrometry/bioinformatic approach. Proteomics Clinical Applications, 1 (6), pp. 605-620. ISSN 1862-8346

ROGERS, A., MILES, A., MCARDLE, S.E., MCCULLOCH, T., POWE, D., BISHOP, M. and REES, R., 2006. Identification and characterisation of T21: A novel cancer testis antigen over expressed in prostate cancer. European Urology Supplements, 5 (14), p. 799. ISSN 1569-9056

BOATENG, J., LANCASHIRE, L., BROWN, P., AHMAD, M., MATHAROO-BALL, B., DAVY, R., YANG, S.Y., ROBERTS, J., TEALE, P., VELLOSO, C., REES, R., BALL, G., GOLDSPINK, G. and CREASER, C., 2006. The use of proteomic and bioinformatics techniques for the detection of protein biomarkers following growth hormone administration. The Internet Journal of Genomics and Proteomics, 2 (2). ISSN 1540-2630

MIAN, S., UGUREL, S., PARKINSON, E., SCHLENZKA, I., DRYDEN, I., LANCASHIRE, L., BALL, G., CREASER, C., REES, R. and SCHADENDORF, D., 2005. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. Journal of Clinical Oncology, 23 (22), pp. 5088-5093. ISSN 0732-183X

LANCASHIRE, L., UGUREL, S., CREASER, C., SCHADENDORF, D., REES, R. and BALL, G., 2005. Utilizing artificial neural networks to elucidate serum biomarker patterns which discriminate between clinical stages in melanoma. Proceedings of the 2005 Ieee Symposium on Computational Intelligence in Bioinformatics and Computational Biology, pp. 455-460.

RAMAGE, J.M., METHERINGHAM, R., MOSS, R., SPENDLOVE, I., REES, R. and DURRANT, L.G., 2004. Comparison of the immune response to a self antigen after DNA immunisation of HLA*A201/H-2Kb and HHD transgenic mice. Vaccine, 22 (1314), pp. 1728-1731. ISSN 0264-410X

MADRIGAL, A.J., RUSAKIEWIEZ, S., DODI, I.A. and REES, R., 2004. Immunotherapy with alloreactive T-cells? Hematology Journal, 5 (3). ISSN 1466-4860

DICKENSON, J.M., REEDER, S., REES, R., ALEXANDER, S. and KENDALL, D., 2003. Functional expression of adenosine A(2A) and A(3) receptors in the mouse dendritic cell line XS-106. European Journal of Pharmacology, 474 (1), pp. 43-51. ISSN 0014-2999

MIAN, S., BALL, G., HORNBUCKLE, J., HOLDING, F., CARMICHAEL, J., ELLIS, I., ALI, S., LI, G., MCARDLE, S.E., CREASER, C. and REES, R., 2003. A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in v. Proteomics, 3 (9), pp. 1725-1737.

DODI, I.A., RUSAKIEWICZ, S., AUBERT, G., CLARKE, R., CHRISTMAS, S., CREASER, C., BONNER, P., REES, R., TRAVERS, P.J. and MADRIGAL, J.A., 2002. Definition of the breakpoint fusion peptides for HLA-A3 and HLA-B8 in CML cells. Tissue Antigens, 59, p. 45. ISSN 0001-2815

TODRYK, S., MCLEAN, C., ALI, S., ENTWISTLE, C., BOURSNELL, M., REES, R. and VILE, R., 1999. Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer. Human Gene Therapy, 10 (17), pp. 2757-2768. ISSN 1043-0342

Patent/Published patent application

LINLEY, A., MATHIEU, M., MCARDLE, S., LU, C. and REES, R., 2017. Breast cancer assay. PCT/GB2013/050794.